In conclusion, the results of our study showed that BMI1 mRNA expression levels in whole blood of NSCLC patients were decreased compared with controls and had an independent prognostic value for patients with advanced NSCLC treated with platinum-based chemotherapy. Here, BMI1 is linked to non-small cell lung carcinoma.